MCAP — MedCap AB (publ) Cashflow Statement
0.000.00%
- SEK6.22bn
- SEK6.22bn
- SEK1.81bn
- 93
- 19
- 31
- 42
Annual cashflow statement for MedCap AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 89.1 | 127 | 171 | 228 | 272 |
Depreciation | |||||
Non-Cash Items | -4.7 | 1 | -1.7 | 1 | -27.4 |
Discontinued Operations | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -36.9 | -87.2 | -172 | -105 | -0.3 |
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 116 | 116 | 85.5 | 228 | 360 |
Capital Expenditures | -24.4 | -60.9 | -44.3 | -39.3 | -66.2 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -108 | -3.9 | -11.8 | -113 | -62.6 |
Acquisition of Business | |||||
Sale/Maturity of Investment | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -132 | -64.8 | -56.1 | -152 | -129 |
Financing Cash Flow Items | -0.1 | -0.1 | -7.3 | 0 | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 145 | -64.1 | 61.2 | -120 | -46.1 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 126 | -6.9 | 96.5 | -48.1 | 182 |